Top Story

Patient-centered medical home program decreased hospital use, lowered care costs

August 22, 2014

In the 3 years since its introduction, CareFirst Blue Cross Blue Shield’s Patient-Centered Medical Home model has resulted in reduced hospital utilization, lower health care costs to members and increased reimbursements for participating panels, Blue Cross Blue Shield announced in a press release.

The company provided 3-year results from their Patient-Centered Medical Home program, which was implemented in 2011. Over 80% of all primary care providers located in the CareFirst service area, which includes parts of Northern Virginia, the District of Columbia and Maryland, are participants.

figure In the Journals

Minor infections may increase children's risk for stroke

August 22, 2014
Children with minor infections had an increased risk for stroke within a 3-day time period, according to study findings published in Neurology.Nancy K. Hills
In the Journals

Bivalirudin lowered bleeding, increased stent thrombosis vs. heparin

August 22, 2014
Bivalirudin was associated with similar mortality, lower bleeding but higher stent thrombosis than heparin in a cohort of patients treated with those drugs after PCI…
In the Journals

CAC score predicted CV risk in patients with chronic kidney disease

August 22, 2014
Inclusion of the coronary artery calcium score improved CV risk prediction in patients with chronic kidney disease.Carotid intima-media thickness and ankle-brachial…
More News Headlines »
CME

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

7/23/2014
Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
figure

Dominic A. Sica, MD, on treatment for resistant hypertension

June 6, 2014
NEW YORK — In this video, Dominic A. Sica, MD, chairman of clinical pharmacology and hypertension at the…
More »
CME

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

12/30/2013
Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »